Skip to main content
  • Conference on Innovations in Tuberculosis 2024

    Tuberculosis (TB) caused 1.6 million deaths in 2021, being the leading cause of death among infectious diseases, above HIV. Yet, it is a curable and preventable disease. While a quarter of the global population has been infected, only 5-10 % of infected individuals develop symptoms. The highest burden regions are South-East Asia, Africa, and the Western Pacific. This bacterial disease is treated by a long course of antibiotics.

  • Staff in EAPOC Project Trained on GeneXpert Machine

    Article by Calvin Mbeda, Adhiambo Phillister, and Frank Angira

    The GeneXpert machine is a molecular diagnostic platform developed by Cepheid, a company specializing in molecular diagnostics. It is used for the rapid and accurate detection of various infectious diseases, including providing counts of HIV viral load, also known as viral load testing. The GeneXpert machine tests clinical samples to quickly identify infectious diseases like tuberculosis (TB). 

  • WP2 & WP3 East Africa Point of Care Viral Load Study (EAPoC-VL) Training.

    Article by Calvin Mbeda, Adhiambo Phillister, and Frank Angira

  • Stakeholder Engagement Unveils Adolescent Perspectives on Intensive Adherence Counselling to Improve Viral load Suppression in Uganda.

    By Elinor Wanyama Chemonges- Stakeholder Engagement Lead EAPOC -VL study

  • Celebration of World Aids Day at KEMRI/CGHR

    Article by Calvin Mbeda, Adhiambo Phillister, and Frank Angira

    World AIDS Day, observed on December 1st every year, is an opportunity for people worldwide to unite in the fight against HIV, show support for people living with HIV, and commemorate those who have died from AIDS-related illnesses. KEMRI/CGHR has been participating in the event ever since its inception, and some of the activities commonly done are: